Medicis And Inamed Corporation (IMDC) Agree To Merge; Combination Will Create A Global Leader In Aesthetics Products And Dermatological Medicine With Annual Revenue In Excess Of $700 Million
10/19/2005 5:13:04 PM
More...
|
Medicis Declares Cash Dividend
10/19/2005 5:13:02 PM
More...
|
Medicis Announces The Launch Of Restylane Rewards - First-Ever Consumer Loyalty Program For A Cosmetic Procedure
10/19/2005 5:12:54 PM
More...
|
Medicis Pharmaceutical (MRX) Announces FDA Approval Of AMMONUL For Urea Cycle Disorder
10/19/2005 5:12:46 PM
More...
|
Medicis Announces FDA Approval Of Its NDA For VANOS, A Patented Class I Corticosteroid For Plaque-Type Psoriasis
10/19/2005 5:12:42 PM
More...
|
Medicis To Present At Merrill Lynch 16th Annual Global Pharmaceutical, Biotechnology & Medical Device Conference
10/19/2005 5:12:38 PM
More...
|
Medicis Amends Strategic Alliance With aaiPharma Inc. (AAII)
10/19/2005 5:12:35 PM
More...
|
Medicis Reports Second Quarter Fiscal 2005 Financial Results; 31% Increase In Revenues And 50% Increase In Earnings Per Share, Absent Special Charges
10/19/2005 5:12:32 PM
More...
|
Medicis Licenses Proprietary Peptide Technology From Ansata Therapeutics, Inc.
10/19/2005 5:12:28 PM
More...
|
Medicis Declares Cash Dividend
10/19/2005 5:12:28 PM
More...
|
|